Zhejiang Sunflower Great Health (300111) Stock Overview
Zhejiang Sunflower Great Health Co., Ltd. More details
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 5/6 |
| Financial Health | 3/6 |
| Dividends | 0/6 |
300111 Community Fair Values
Create NarrativeSee what others think this stock is worth. Follow their fair value or set your own to get alerts.
Zhejiang Sunflower Great Health Co., Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CN¥8.73 |
| 52 Week High | CN¥10.28 |
| 52 Week Low | CN¥2.33 |
| Beta | 0.51 |
| 1 Month Change | 14.12% |
| 3 Month Change | 142.50% |
| 1 Year Change | 158.28% |
| 3 Year Change | 194.93% |
| 5 Year Change | 135.95% |
| Change since IPO | -20.17% |
Recent News & Updates
Recent updates
Zhejiang Sunflower Great Health Co., Ltd.'s (SZSE:300111) 60% Share Price Surge Not Quite Adding Up
Oct 08
Zhejiang Sunflower Great Health (SZSE:300111) Might Have The Makings Of A Multi-Bagger
Aug 05Some Shareholders Feeling Restless Over Zhejiang Sunflower Great Health Co., Ltd.'s (SZSE:300111) P/S Ratio
Jul 05Zhejiang Sunflower Great Health's (SZSE:300111) Promising Earnings May Rest On Soft Foundations
May 03Zhejiang Sunflower Great Health (SZSE:300111) Is Doing The Right Things To Multiply Its Share Price
Apr 17Zhejiang Sunflower Great Health Co., Ltd. (SZSE:300111) Stock Rockets 25% As Investors Are Less Pessimistic Than Expected
Mar 08Shareholder Returns
| 300111 | CN Pharmaceuticals | CN Market | |
|---|---|---|---|
| 7D | 11.1% | 1.8% | 0.5% |
| 1Y | 158.3% | 21.1% | 24.7% |
Return vs Industry: 300111 exceeded the CN Pharmaceuticals industry which returned 21.1% over the past year.
Return vs Market: 300111 exceeded the CN Market which returned 24.7% over the past year.
Price Volatility
| 300111 volatility | |
|---|---|
| 300111 Average Weekly Movement | 17.3% |
| Pharmaceuticals Industry Average Movement | 4.8% |
| Market Average Movement | 5.5% |
| 10% most volatile stocks in CN Market | 9.4% |
| 10% least volatile stocks in CN Market | 3.0% |
Stable Share Price: 300111's share price has been volatile over the past 3 months compared to the CN market.
Volatility Over Time: 300111's weekly volatility has increased from 10% to 17% over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2005 | 331 | Huaxin Shi | www.sunowe.com |
Zhejiang Sunflower Great Health Co., Ltd. engages in the research, development, production, and sale of anti-infectious, cardiovascular, digestive system and other drugs worldwide. It offers clarithromycin API and tablets, an anti-infective drug used for nasopharyngeal infection, lower respiratory tract infection, skin and soft tissue infection, acute otitis media, mycoplasma pneumoniae pneumonia, urethritis and cervicitis, as well as acute pharyngitis and acute tonsillitis; and azithromycin dispersible tablets for sinusitis, acute otitis media, acute bronchitis, acute exacerbation of chronic bronchitis, streptococcus pneumoniae, pneumonia, haemophilus influenzae, mycoplasma pneumoniae, urethritis, cervicitis and skin and soft tissue infection.
Zhejiang Sunflower Great Health Co., Ltd. Fundamentals Summary
| 300111 fundamental statistics | |
|---|---|
| Market cap | CN¥11.24b |
| Earnings (TTM) | CN¥6.35m |
| Revenue (TTM) | CN¥302.92m |
Is 300111 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 300111 income statement (TTM) | |
|---|---|
| Revenue | CN¥302.92m |
| Cost of Revenue | CN¥241.91m |
| Gross Profit | CN¥61.01m |
| Other Expenses | CN¥54.66m |
| Earnings | CN¥6.35m |
Last Reported Earnings
Sep 30, 2025
Next Earnings Date
n/a
| Earnings per share (EPS) | 0.0049 |
| Gross Margin | 20.14% |
| Net Profit Margin | 2.10% |
| Debt/Equity Ratio | 0.4% |
How did 300111 perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/11/02 05:54 |
| End of Day Share Price | 2025/10/31 00:00 |
| Earnings | 2025/09/30 |
| Annual Earnings | 2024/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Zhejiang Sunflower Great Health Co., Ltd. is covered by 2 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Xin He | Huatai Research |
| Ze Yun Dou | Ping An Securities Co. Ltd. |